Realcan Pharmaceutical Group Co., Ltd. (002589.SZ)
CNY 2.95
(4.24%)
CNY 2.95
(4.24%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 822.06 Million CNY | -50.54% |
| 2022 | 1.67 Billion CNY | -56.44% |
| 2021 | 3.83 Billion CNY | -22.86% |
| 2020 | 4.97 Billion CNY | -27.02% |
| 2019 | 6.81 Billion CNY | 5.01% |
| 2018 | 6.49 Billion CNY | 51.17% |
| 2017 | 4.29 Billion CNY | 75.53% |
| 2016 | 2.44 Billion CNY | 128.8% |
| 2015 | 1.06 Billion CNY | 51.64% |
| 2014 | 705.38 Million CNY | 38.54% |
| 2013 | 509.16 Million CNY | 35.09% |
| 2012 | 376.9 Million CNY | 43.99% |
| 2011 | 261.76 Million CNY | 42.45% |
| 2010 | 183.75 Million CNY | 33.5% |
| 2009 | 137.63 Million CNY | 35.41% |
| 2008 | 101.64 Million CNY | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q3 | 275.1 Million CNY | 33.44% |
| 2024 Q1 | 243.13 Million CNY | 2728.39% |
| 2024 Q2 | 213.46 Million CNY | -12.2% |
| 2023 Q3 | 285.27 Million CNY | 33.6% |
| 2023 Q4 | 8.59 Million CNY | -96.99% |
| 2023 FY | 827.03 Million CNY | -50.54% |
| 2023 Q1 | 319.63 Million CNY | 302.7% |
| 2023 Q2 | 213.52 Million CNY | -33.2% |
| 2022 Q3 | 510.84 Million CNY | -15.56% |
| 2022 Q4 | -157.68 Million CNY | -130.87% |
| 2022 FY | 1.67 Billion CNY | -56.44% |
| 2022 Q1 | 713.92 Million CNY | 5.05% |
| 2022 Q2 | 604.98 Million CNY | -15.26% |
| 2021 FY | 3.83 Billion CNY | -22.86% |
| 2021 Q2 | 1.11 Billion CNY | 2.9% |
| 2021 Q3 | 966.1 Million CNY | -13.14% |
| 2021 Q4 | 679.58 Million CNY | -29.66% |
| 2021 Q1 | 1.08 Billion CNY | -7.68% |
| 2020 Q4 | 1.17 Billion CNY | -18.18% |
| 2020 Q3 | 1.43 Billion CNY | 8.73% |
| 2020 FY | 4.97 Billion CNY | -27.02% |
| 2020 Q1 | 1.05 Billion CNY | -33.67% |
| 2020 Q2 | 1.31 Billion CNY | 24.32% |
| 2019 Q2 | 1.79 Billion CNY | 11.19% |
| 2019 Q3 | 1.82 Billion CNY | 1.81% |
| 2019 FY | 6.81 Billion CNY | 5.01% |
| 2019 Q1 | 1.61 Billion CNY | -2.54% |
| 2019 Q4 | 1.59 Billion CNY | -12.44% |
| 2018 Q3 | 1.81 Billion CNY | 6.86% |
| 2018 FY | 6.49 Billion CNY | 51.17% |
| 2018 Q4 | 1.65 Billion CNY | -9.14% |
| 2018 Q2 | 1.7 Billion CNY | 28.74% |
| 2018 Q1 | 1.32 Billion CNY | -5.96% |
| 2017 FY | 4.29 Billion CNY | 75.53% |
| 2017 Q3 | 1.1 Billion CNY | 16.5% |
| 2017 Q4 | 1.4 Billion CNY | 26.78% |
| 2017 Q2 | 951.64 Million CNY | 14.69% |
| 2017 Q1 | 829.77 Million CNY | -0.98% |
| 2016 FY | 2.44 Billion CNY | 128.8% |
| 2016 Q2 | 540.32 Million CNY | 40.54% |
| 2016 Q3 | 684.48 Million CNY | 26.68% |
| 2016 Q4 | 837.99 Million CNY | 22.43% |
| 2016 Q1 | 384.47 Million CNY | 8.47% |
| 2015 Q2 | 250.47 Million CNY | 36.36% |
| 2015 Q3 | 280.99 Million CNY | 12.19% |
| 2015 Q4 | 354.45 Million CNY | 26.14% |
| 2015 FY | 1.06 Billion CNY | 51.64% |
| 2015 Q1 | 183.68 Million CNY | -19.7% |
| 2014 Q3 | 186 Million CNY | 12.74% |
| 2014 Q2 | 164.99 Million CNY | 31.34% |
| 2014 Q1 | 125.62 Million CNY | -19.08% |
| 2014 FY | 705.38 Million CNY | 38.54% |
| 2014 Q4 | 228.75 Million CNY | 22.98% |
| 2013 Q2 | 119.78 Million CNY | 22.52% |
| 2013 FY | 509.16 Million CNY | 35.09% |
| 2013 Q4 | 155.24 Million CNY | 13.85% |
| 2013 Q3 | 136.36 Million CNY | 13.83% |
| 2013 Q1 | 97.76 Million CNY | -19.45% |
| 2012 Q4 | 121.36 Million CNY | 25.76% |
| 2012 Q3 | 96.51 Million CNY | 15.37% |
| 2012 Q2 | 83.65 Million CNY | 10.99% |
| 2012 Q1 | 75.37 Million CNY | -12.36% |
| 2012 FY | 376.9 Million CNY | 43.99% |
| 2011 FY | 261.76 Million CNY | 42.45% |
| 2011 Q3 | 66.94 Million CNY | 11.48% |
| 2011 Q2 | 60.04 Million CNY | 23.12% |
| 2011 Q1 | 48.77 Million CNY | -12.79% |
| 2011 Q4 | 85.99 Million CNY | 28.47% |
| 2010 Q2 | 46.63 Million CNY | 38.38% |
| 2010 Q4 | 55.92 Million CNY | 17.71% |
| 2010 FY | 183.75 Million CNY | 33.5% |
| 2010 Q1 | 33.69 Million CNY | 0.0% |
| 2010 Q3 | 47.51 Million CNY | 1.89% |
| 2009 FY | 137.63 Million CNY | 35.41% |
| 2008 FY | 101.64 Million CNY | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| China National Accord Medicines Corporation Ltd. | 9 Billion CNY | 90.872% |
| Shenzhen Glory Medical Co.,Ltd. | 155 Million CNY | -430.349% |